CD4+ Th Cell-Derived Extracellular Vesicles Orchestrate CD8+ T Cells and Eosinophils to Enhance Anti-Tumor Immunity
Zhaoxin Yang, Tianyu Lan, Rui Diao, Zhirang Zhang, Yumeng Ma, Xiaozhou Zhang, Yongting Feng, Yanjun Chen, Yuan Li, Yuting Wei, Wenli Fang, Zhangyan Jing, Aihui Fan, Jinqiang Wang, Xin Liang, Xudong Z
Journal:Small
IF:11.8
DOI:10.1002/smll.202513605
PMID:42125790
Published:2026-05-13
research field:分子生物学细胞生物学癌症生物学免疫学细胞外囊泡研究
Abstract
CD4 + T cells play a pivotal role in anti-tumor immunity by assisting CD8 + T cells in eliminating MHC I + tumor cells and promoting immune responses against MHC-deficient tumors through myeloid-cell recruitment. Extracellular vesicles (EVs) are increasingly recognized as important mediators of intercellular immune communication; however, how CD4 + T helper (Th)-derived EVs modulate tumor immune cells, including CD8 + T cells and eosinophils, to orchestrate anti-tumor responses remains poorly understood. Here, we show that immune checkpoint molecules, including PD-1 and TIM-3, and the cytokine IL-5 are enriched on CD4 + Th cell microvilli and EVs. Activated CD4 + Th cells released both exosomes and ectosomes, which cooperatively suppressed tumor progression through two complementary mechanisms. First, CD4 + Th-derived exosomes and ectosomes displayed immune checkpoint receptors such as PD-1 and TIM-3 on their surface, thereby intercepting tumor-derived inhibitory signals, reversing T cell exhaustion, and enhancing cytotoxic T cell activity. Second, CD4 + Th-derived EVs carried IL-5 and other effector molecules that promoted JAK–STAT signaling, eosinophil recruitment to tumor sites, and eosinophil-mediated tumor cell killing through degranulation. Moreover, CD4 + Th-derived EVs remodeled the tumor microenvironment by enhancing CD8 + T cell and eosinophil infiltration and activation, suggesting their potential role in immune regulation and cancer therapy.
本文使用的Yeasen产品


